Synagis Use in CF Babies Carries No Lasting Benefits into Childhood, Study Finds - Cystic Fibrosis News Today

Synagis Use in CF Babies Carries No Lasting Benefits into Childhood, Study Finds  Cystic Fibrosis News Today

A CF Foundation Patient Registry study found infants treated for at least one year with Synagis had lung health similar to those who were not at age 7.